Research & Discovery
Setting Limits to Stop the Gambling Epidemic
The balance of money collected from gambling is a transfer from the poor to the rich, says Thomas Babor, addiction researcher at UConn Health.
The Struggle to Find Affordable Housing in Hartford
A new exhibit at the Dodd Center, opening April 17, documents the racism and discrimination that many Hartford residents have experienced over the years, leaving them with little access to affordable housing.
Crystallizing Knowledge with a Learning Machine
UConn researchers working with Pfizer used machine learning to figure out the best way to coax a drug into solid form for the development of pharmaceuticals.
How Brands are Circumventing Marketing Regulations
A UConn marketing professor found that financial companies employing ‘umbrella branding’ may have used advertising to drive customers to all their products, despite regulations designed to safeguard investors.
New Program Looks Local to Improve Road Safety
From rumble strips to retroreflectometers - the Safety Circuit Rider Program administered by UConn helps keep local drivers safe.
Op-ed: The Replication Crisis is Good for Science
According to recent reports, about two-thirds of studies replicated findings to some degree, but the strength of the findings was often weaker than claimed, writes educational psychologist Eric Loken.
Study: After-school Programs Improve Academic Outcomes
A study of study over 9,000 students attending more than 100 after-school programs in Connecticut found those who participated had higher school attendance and higher academic performance.
New Technology Designed to Reduce Mortality Rates in Cancer Patients
A pair of Ph.D. students developed a technology that takes a patient’s tumor cells and grows them outside of the body to test different cancer treatments.
UConn in Top 10 Worldwide for Biological Data Research Output
UConn tied for ninth-place with Princeton for research output in the fields of bioinformatics and computational biology, according to CSRankings.
Drug Discovery Partnership with AI Biotech Company Reaps Promising Early Results
At UConn Health, the technology is being used to pursue therapeutic treatments for strokes, for which there is “an urgent need for novel therapies that can move rapidly into clinical trials,” says Rajkumar Verma.